Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: A transatlantic, randomized, double-blind, controlled study in 1670 patients

British Journal of Dermatology

Volumn 161, Issue 5, 2009, Pages 1180-1189

  Gollnick, H P M ^a   Draelos, Z ^b   Glenn, M J ^c   Rosoph, L A ^d   Kaszuba, A ^e   Cornelison, R ^f   Gore, B ^g   Liu, Y ^g   Graeber, M ^g  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Advance Dermatology and Laser Medical Center Inc   (United States)

^d North Bay Dermatology Centre   (Canada)

^e Specjalistyczne Gabinety Lekarskie Dermed   (Poland)

^f UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^g Galderma Research and Development   (United States)

Author keywords

Acne; Adapalene; Benzoyl peroxide; Combination therapy; Randomized controlled trial

Indexed keywords

ADAPALENE; BENZOYL PEROXIDE; DRUG VEHICLE;

ACNE VULGARIS; ADOLESCENT; ADULT; APPENDICITIS; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY SKIN; ERYTHEMA; FEMALE; FURUNCULOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHOOL CHILD; SCOLIOSIS; SKIN BURNING SENSATION; SPONTANEOUS ABORTION;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; BENZOYL PEROXIDE; CHILD; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; GELS; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 71049142353     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09209.x     Document Type: Article

References (28)

1. Pawin H, Beylot C, Chivot M et al. Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol 2004 14 : 4 12.
2. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol 2003 49 (Suppl. S200 10.
3. Gollnick H, Cunliffe W, Berson D et al. Management of acne. A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003 49 (Suppl. S1 37.
4. Krautheim A, Gollnick H. Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet 2003 42 : 1287 1304.
5. Brogden RN, Goa KE. Adapalene: a review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs 1997 53 : 511 519.
6. Michel S, Jomard A, Demarchez M. Pharmacology of adapalene. Br J Dermatol 1998 139 (Suppl. 52 3 7.
7. Tenaud I, Khammari A, Dreno B. In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions. Exp Dermatol 2007 16 : 500 506.
8. Shroot B, Michel S. Pharmacology and chemistry of adapalene. J Am Acad Dermatol 1997 36 : S96 103.
9. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA 2004 292 : 726 735.
10. Cunliffe WJ, Poncet M, Loesche C, Verschoore M. A comparison of the efficacy and tolerability of adapalene 0·1% gel versus tretinoin 0·025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials. Br J Dermatol 1998 139 : 48 56.
11. Waugh J, Noble S, Scott LJ. Adapalene: a review of its use in the treatment of acne vulgaris. Drugs 2004 64 : 1465 1478.
12. Leyden JJ. Current issues in antimicrobial therapy for the treatment of acne. J Eur Acad Dermatol Venereol 2001 15 (Suppl. 3 51 5.
13. Plewig G, Kligman AM. Acne and Rosacea, 3rd edn. New York : Springer-Verlag, 2000.
14. Webster GF, Leyden JJ, McGinley KJ, McArthur WP. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracyclines and erythromycin. Antimicrob Agents Chemother 1982 21 : 770 772.
15. Melski JW, Arndt K. Current concepts: topical therapy for acne. N Engl J Med 1980 302 : 503 506.
16. Bikowski JB. Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel as monotherapy and in combination. J Drugs Dermatol 2005 4 : 164 171.
17. Martin B, Meunier C, Montels D, Watts O. Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. Br J Dermatol 1998 139 (Suppl. 52 8 11.
18. Thiboutot DM, Weiss J, Bucko A et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol 2007 57 : 791 799.
19. Pariser DM, Westmoreland P, Morris A et al. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0·1% and benzoyl peroxide 2·5% for the treatment of acne vulgaris. J Drugs Dermatol 2007 6 : 899 905.
20. Brand B, Gilbert R, Baker MD et al. Cumulative irritancy comparison of adapalene gel 0·1% versus other retinoid products when applied in combination with topical antimicrobial agents. J Am Acad Dermatol 2003 49 (Suppl. S227 32.
21. Caron D, Sorba V, Clucas A, Verschoore M. Skin tolerance of adapalene 0·1% gel in combination with other topical antiacne treatments. J Am Acad Dermatol 1997 36 : S113 15.
22. Wolf JE Jr., Kaplan D, Kraus SJ et al. Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study. J Am Acad Dermatol 2003 49 (Suppl. S211 17.
23. Cunliffe WJ, Meynadier J, Alirezai M et al. Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0·1%, versus lymecycline plus gel vehicle. J Am Acad Dermatol 2003 49 (Suppl. S218 26.
24. Zhang JZ, Li LF, Tu YT, Zheng J. A successful maintenance approach in inflammatory acne with adapalene gel 0·1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. J Dermatolog Treat 2004 15 : 372 378.
25. Thiboutot D, Shalita A, Yamauchi PS et al. Combination therapy with adapalene gel 0·1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study. SkinMED 2005 4 : 138 146.
26. Bowman S, Gold M, Nasir A, Vamvakias G. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study. J Drugs Dermatol 2005 4 : 611 618.
27. Lookingbill DP, Chalker DK, Lindholm JS et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 1997 37 : 590 595.
28. Clindamycin/tretinoin. Drugs R D 2005 6 : 231 234.